CKIP-1: a scaffold protein and potential therapeutic target integrating multiple signaling pathways and physiological

Jing Nie1, Lin Liu, Fuchu He

  • 1Department of Molecular Biology, Institute of Basic Medical Science, PLA General Hospital, Beijing, China.

Ageing Research Reviews
|August 11, 2012
PubMed

Insights

The scaffold protein CKIP-1 (also known as PLEKHO1) interacts with multiple proteins and regulates cell processes. CKIP-1 shows promise for treating osteoporosis and may act as a tumor suppressor.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • CKIP-1 (PLEKHO1) is a scaffold protein interacting with diverse proteins like CK2α, Akt, and ATM.
  • It regulates cellular functions via plasma membrane recruitment, transcriptional, and posttranscriptional modulation.
  • CKIP-1 exhibits cell type-dependent subcellular localization and stress-regulated nucleocytoplasmic shuttling.

Purpose of the Study:

  • To elucidate the multifaceted roles of CKIP-1 in cellular signaling pathways.
  • To investigate the therapeutic potential of CKIP-1 in bone formation and cancer.

Main Methods:

  • Protein-protein interaction analysis.
  • Cellular localization studies.
  • Functional assays related to cell growth, apoptosis, and differentiation.

Main Results:

  • CKIP-1 acts as a crucial adaptor in signaling pathways governing cell growth, apoptosis, differentiation, cytoskeleton dynamics, and bone formation.
  • Studies in rat models identified CKIP-1 as a potential therapeutic target for osteoporosis.
  • Emerging evidence suggests CKIP-1 possesses tumor suppressor functions.

Conclusions:

  • CKIP-1 is a versatile protein with significant implications in fundamental cellular processes.
  • CKIP-1 represents a promising therapeutic target for osteoporosis and potentially cancer treatment.

Related Concept Videos

Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...